2-苯基-1H-苯并咪唑-1-乙酸 | 92437-42-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 中文名称: 2-苯基-1H-苯并咪唑-1-乙酸
• 英文名称: 2-(2-phenyl-1H-benzo[d]imidazol-1-yl)acetic acid
• 英文别名: 2-(2-phenyl-3H-benzimidazol-1-ium-1-yl)acetate
• CAS: 92437-42-8
• 化学式: C₁₅H₁₂N₂O₂
• mdl: MFCD09706566
• 分子量: 252.272
• InChiKey: YIZCZAATUVLJSG-UHFFFAOYSA-N

物化性质

• 熔点：
  256-257 °C(Solv: ethyl acetate (141-78-6))
• 沸点：
  499.3±47.0 °C(Predicted)
• 密度：
  1.27±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.066
• 拓扑面积：
  55.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-苯基-1H-苯并咪唑-1-乙酸 在 sodium hydroxide 、 1-羟基苯并三唑 、 臭氧 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 生成 (3S)-5,5-difluoro-3-[[(2S)-4-methyl-2-[[2-(2-phenylbenzimidazol-1-yl)acetyl]amino]pentanoyl]amino]-2-oxo-pentanoic acid
  参考文献：
  名称：

  Capped dipeptide α-Ketoacid inhibitors of the HCV NS3 protease

  摘要：

  The N-terminal aminoacid of alpha-ketotripeptide inhibitors of the hepatitis C virus NS3 protease can be replaced with an alpha-hydroxy acid, leading to capped dipeptide inhibitors such as 20 with an IC50 value of 3.0 muM. The importance of the lipophilic side chain interactions at S3 of the protease and the requirement of the capping residue with R configuration have been explained by molecular modeling studies. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00691-1
• 作为产物：
  描述：

  methyl 2-(2-phenyl-1H-benzo[d]imidazol-1-yl)acetate 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 以80%的产率得到2-苯基-1H-苯并咪唑-1-乙酸
  参考文献：
  名称：

  BENZIMIDAZOLE DERIVATIVES AS MITOCHONDRIAL FUNCTION MODULATORS

  摘要：

  提供了一种调节线粒体功能并具有药用活性作为神经保护剂的苯并咪唑衍生物，以及包含该化合物作为活性成分的药物组合物。

  公开号：

  US20140114067A1

文献信息

• Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection
  作者：Qi Li、Ying Chen、Shuaishuai Xing、Qinghong Liao、Baichen Xiong、Yuanyuan Wang、Weixuan Lu、Siyu He、Feng Feng、Wenyuan Liu、Yao Chen、Haopeng Sun

  DOI：10.1021/acs.jmedchem.1c00167

  日期：2021.5.27

  Butyrylcholinesterase (BChE) has been considered as a potential therapeutic target for Alzheimer’s disease (AD) because of its compensation capacity to hydrolyze acetylcholine (ACh) and its close association with Aβ deposit. Here, we identified S06-1011 (hBChE IC50 = 16 nM) and S06-1031 (hBChE IC50 = 25 nM) as highly effective and selective BChE inhibitors, which were proved to be safe and long-acting

  丁酰胆碱酯酶（BChE）因其水解乙酰胆碱（ACh）的补偿能力及其与Aβ沉积的密切关系而被认为是阿尔茨海默病（AD）的潜在治疗靶点。在这里，我们确定了S06-1011 ( h BChE IC 50 = 16 nM) 和S06-1031 ( h BChE IC 50 = 25 nM) 为高效、选择性 BChE 抑制剂，并被证明是安全且长效的。候选化合物在东莨菪碱和 Aβ 1-42肽诱导的认知缺陷模型中表现出神经保护作用和改善认知的能力。最佳候选者S06-1011提高了BChE底物ghrelin的水平，可以起到改善精神情绪食欲的作用。 S06-1011处理组的体重增加显着增加。因此，抑制BChE不仅对痴呆具有保护作用，而且对治疗和护理也有很大作用。
• 一种苯并咪唑类化合物及其制备方法和应用
  申请人：陕西科技大学

  公开号：CN104130249B

  公开（公告）日：2017-04-26

  一种2‑取代‑N‑[5‑(2‑氨基‑1,3,4‑噻二唑)‑亚甲基]‑苯并咪唑及其制备方法和应用，首先以苯并咪唑类化合物和氯乙酸钾为原料，乙醇为溶剂回流反应制得1‑羧甲基‑苯并咪唑类化合物；然后以多聚磷酸、1‑羧甲基‑苯并咪唑类化合物以及氨基硫脲为原料，回流反应制得2‑取代‑N‑[5‑(2‑氨基‑1,3,4‑噻二唑)‑亚甲基]‑苯并咪唑；接着以2‑取代‑N‑[5‑(2‑氨基‑1,3,4‑噻二唑)‑亚甲基]‑苯并咪唑、芳醛以及对甲苯磺酸为原料进行固相反应，制得2‑取代‑N‑[5‑(2‑氨基‑1,3,4‑噻二唑)‑亚甲基]‑苯并咪唑。本发明反应过程简单，设备要求低，操作简单，目标产物产率较高，对环境污染小，制得的2‑取代‑N‑[5‑(2‑(N‑芳基亚甲基)氨基‑1,3,4‑噻二唑)‑亚甲基]‑苯并咪唑能够在制备抑制大肠杆菌的药物中应用。
• Design, synthesis, and structure–activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands
  作者：Taketoshi Okubo、Ryoko Yoshikawa、Shigeyuki Chaki、Shigeru Okuyama、Atsuro Nakazato

  DOI：10.1016/j.bmc.2004.04.025

  日期：2004.7

  The peripheral benzodiazepine receptor (PBR) is pharmacologically distinct from the central benzodiazepine receptor (CBR) and has been identified in a wide range of peripheral tissues as well as in the central nervous system. Although numerous studies have been performed of it, the physiological roles and functions of the PBR are still unclear. In the present study, in exploring new types of ligands

  外周苯二氮卓类受体（PBR）在药理上不同于中枢苯二氮卓类受体（CBR），并且已在广泛的外周组织以及中枢神经系统中得到鉴定。尽管已经对其进行了大量研究，但是PBR的生理作用和功能仍不清楚。在本研究中，在探索新型的PBR配体时，我们发现由FGIN-1-27设计的一系列具有四环系统的新化合物对PBR表现出高亲和力。我们准备并评估了它们的PBR亲和力。结合测试的结果表明，12e和12f是其中最有效的PBR配体（12e：IC（50）= 0.44nM，12f：IC（50）= 0.37nM）。在本文中，我们介绍了设计，综合，
• Discovery of benzimidazole derivatives as modulators of mitochondrial function: A potential treatment for Alzheimer's disease
  作者：TaeHun Kim、Ha Yun Yang、Beoung Gun Park、Seo Yun Jung、Jong-Hyun Park、Ki Duk Park、Sun-Joon Min、Jinsung Tae、Hyejin Yang、Suengmok Cho、Sung Jin Cho、Hyundong Song、Inhee Mook-Jung、Jiyoun Lee、Ae Nim Pae

  DOI：10.1016/j.ejmech.2016.11.017

  日期：2017.1

  In this study, we designed a library of compounds based on the structures of well-known ligands of the 18 kDa translocator protein (TSPO), one of the putative components of the mPTP. We performed diverse mitochondrial functional assays to assess their ability to restore cells from A beta-induced toxicity in vitro and in vivo. Among tested compounds, compound 25 effectively improved cognitive function in animal models of AD. Given the excellent in vitro and in vivo activity and a favorable pharmacokinetic profile of compound 25, we believe that it can serve as a promising lead compound for a potential treatment option for AD. (C) 2016 Elsevier Masson SAS. All rights reserved.
• A Metallaphotoredox Method for the Expansion of Benzyl SAR on Electron-Deficient Amines
  作者：Meghan D. Shea、Umar Faruk Mansoor、Brett A. Hopkins

  DOI：10.1021/acs.orglett.9b04587

  日期：2020.2.7

  A metallaphotoredox reaction is described that allows for the efficient exploration of benzyl structure-activity relationships on electron-deficient amines. Typically, accessing a variety of benzyl groups on these substrates can be difficult due to the limited availability of the prerequisite building blocks, namely benzyl halides. However, the use of aryl bromides in this metallaphotoredox reaction allows for greater diversity in the benzyl piece. The reaction scope is discussed herein, including conditions for product scaleup using flow.

表征谱图